return to news
  1. Anthem Biosciences IPO allotment finalised: How to check status online on KFin Technologies, NSE, BSE; check listing date

Market News

Anthem Biosciences IPO allotment finalised: How to check status online on KFin Technologies, NSE, BSE; check listing date

Upstox

3 min read | Updated on July 18, 2025, 08:10 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Anthem Biosciences IPO allotment: The Bengaluru-based company had set the price range at ₹540-₹570 per share, and a lot consisted of 26 shares. The company seeks to raise ₹3,395 crore via an offer for sale (OFS) of 5.96 crore shares.

Anthem is a contract research, development and manufacturing organisation (CRDMO) involved in drug discovery, development and manufacturing. | Image: Anthembio.com

Anthem is a contract research, development and manufacturing organisation (CRDMO) involved in drug discovery, development and manufacturing. | Image: Anthembio.com

Anthem Biosciences IPO allotment: The basis of allotment of Anthem Biosciences Ltd was finalised on Thursday, July 17. The details related to bid finalisation are available on the websites of NSE, BSE and KFin Technologies.

The initial share sale was subscribed to 63.86 times during the three-day bidding period, as investors applied for 2,81,45,24,128 shares compared to 4,40,70,682 shares on offer, according to cumulative data on BSE.

The bidding was led by qualified institutional buyers (QIBs) who subscribed their portion 182.65 times, followed by non-institutional investors (NIIs) who subscribed 42.35 times, and retail investors at 5.64 times subscription.

The Bengaluru-based company had set the price band at ₹540-₹570 per share, and a lot consisted of 26 shares. The company seeks to raise ₹3,395 crore via an offer for sale (OFS) of 5.96 crore shares.

Since the IPO is solely an OFS, the firm will not get any funds from the public issue. The proceeds will go to the selling shareholders.

Citigroup Global Markets India, Nomura Financial Advisory and Securities (India), JM Financial, and JP Morgan India were the book-running lead managers for the issue.

Before the IPO, the company had mobilised ₹1,016 crore from anchor investors.

Anthem Biosciences IPO allotment date: When and where to check

Anthem Biosciences IPO allotment details will be out on the portals of the BSE, the NSE and registrar KFin Technologies on Thursday, July 17. The status will likely be finalised before midnight.

How to check Anthem Biosciences IPO allotment status online on NSE

How to check Anthem Biosciences IPO allotment status online on the BSE website

Anthem Biosciences IPO allotment status on Kfin Technologies; check steps

  • Head to registrar's portal https://ris.kfintech.com/ipostatus/)
  • Five links will appear on screen. Click on any one.
  • In the ‘Select IPO’ dropdown, choose 'Anthem Biosciences Ltd'
  • Fill in any one: IPO application number, PAN, or Demat account number
  • After the Captcha verification, click on 'Submit'

Anthem Biosciences IPO listing date

Shares of Anthem Biosciences are expected to list on stock exchanges – the NSE and the BSE – on Monday, July 21.

Anthem is a contract research, development and manufacturing organisation (CRDMO) involved in drug discovery, development and manufacturing.

Anthem Biosciences IPO GMP

According to investorgain.com, the unlisted shares of Anthem Biosciences are trading at ₹714 per share, reflecting a grey market premium (GMP) of 25.26% or ₹144 over the upper price band of ₹570.
Disclaimer: Grey Market Premium, or GMP, is an unofficial indicator of market sentiment toward an IPO. It is not regulated by the stock exchanges or SEBI. Upstox neither supports nor encourages grey market trading. Investors are advised to conduct their own research or consult an expert before making any investment decisions.
To learn more about IPOs, their listings, schedules, and upcoming IPOs, visit our page.
SIP
Consistency beats timing.
promotion image

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.